Akero Therapeutics, Inc. (AKRO) has a market capitalization of $4.5B and trades at $54.65. The 52-week range is 21.34-58.4.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -14.6, Earnings Per Share (EPS) of $-3.75.
The stock has a beta of -0.40, operates in the Healthcare sector.
